comparemela.com
  1. Home
  2. Live Updates
  3. Rainvectis - Breaking News

Latest Breaking News On - Rainvectis - Page 1 : comparemela.com

AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsidiary BrainVectis for AB-1003, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy (LGMD)

LGMD is a Rare Form of Muscular Dystrophy with No Approved Therapy RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2023 /PRNewswire/ Asklepios BioPharmaceutical, Inc. (AskBio), a wholly

United statesResearch triangle parkNorth carolinaUnited kingdomCity ofDennis riedlSheila mikhailBayer agNational centerNational institutes of healthEuropean commissionDrug administrationNational institutes of health medlineRare diseases information centerTranslational sciencesTrademark office

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.